Grace Therapeutics (L8S.F) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.24
-0.13
-0.02
0.09

Details

Expected EPS
-0.23591120000000002
Actual EPS
-0.11795560000000001
Surprise EPS
0.12
Surprise Percent
+50%

Description

⁨Grace Therapeutics⁩ (⁦L8S.F⁩) has reported earnings of ⁦-0.11795560000000001⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts